1. Home
  2. CSBR vs YXT Comparison

CSBR vs YXT Comparison

Compare CSBR & YXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • YXT
  • Stock Information
  • Founded
  • CSBR 1985
  • YXT 2011
  • Country
  • CSBR United States
  • YXT China
  • Employees
  • CSBR N/A
  • YXT N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • YXT
  • Sector
  • CSBR Health Care
  • YXT
  • Exchange
  • CSBR Nasdaq
  • YXT NYSE
  • Market Cap
  • CSBR 151.0M
  • YXT 129.2M
  • IPO Year
  • CSBR 1986
  • YXT 2024
  • Fundamental
  • Price
  • CSBR $10.17
  • YXT $1.95
  • Analyst Decision
  • CSBR Strong Buy
  • YXT
  • Analyst Count
  • CSBR 1
  • YXT 0
  • Target Price
  • CSBR $8.00
  • YXT N/A
  • AVG Volume (30 Days)
  • CSBR 46.1K
  • YXT 17.9K
  • Earning Date
  • CSBR 03-11-2025
  • YXT 03-04-2025
  • Dividend Yield
  • CSBR N/A
  • YXT N/A
  • EPS Growth
  • CSBR N/A
  • YXT N/A
  • EPS
  • CSBR N/A
  • YXT 3.06
  • Revenue
  • CSBR $53,571,000.00
  • YXT $48,030,651.00
  • Revenue This Year
  • CSBR $14.19
  • YXT N/A
  • Revenue Next Year
  • CSBR $10.11
  • YXT N/A
  • P/E Ratio
  • CSBR N/A
  • YXT $0.64
  • Revenue Growth
  • CSBR 7.19
  • YXT N/A
  • 52 Week Low
  • CSBR $3.60
  • YXT $1.33
  • 52 Week High
  • CSBR $11.99
  • YXT $11.00
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 48.12
  • YXT N/A
  • Support Level
  • CSBR $10.32
  • YXT N/A
  • Resistance Level
  • CSBR $11.33
  • YXT N/A
  • Average True Range (ATR)
  • CSBR 0.99
  • YXT 0.00
  • MACD
  • CSBR -0.20
  • YXT 0.00
  • Stochastic Oscillator
  • CSBR 29.57
  • YXT 0.00

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS

Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.

Share on Social Networks: